The prevalence and predictive value of individual criteria for metabolic syndrome in schizophrenia: A Northern Finland 1966 Birth Cohort Study
- 10 March 2010
- journal article
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 11 (2-2) , 262-267
Abstract
The metabolic syndrome (MetS) is associated with elevated risk of diabetes and cardiovascular morbidity. However, little is known of the sensitivity, specificity and predictive value of individual criteria in patients with schizophrenia. We studied the prevalence of MetS using the International Diabetes Federation (IDF) and adapted National Cholesterol Education Program (NCEP-ATPIII) criteria in the Northern Finland 1966 Birth Cohort population. In addition, the sensitivity, specificity and predictive values for individual criteria were determined. Both adapted NCEP-ATPIII and IDF criteria for MetS identified the same cases (29% of all schizophrenia patients). Among the IDF criteria, hypertriglyceridemia had the highest sensitivity, correctly identifying 77.8% of the patients. Reduced HDL cholesterol was the most specific criteria, with 95% specificity equalling a positive likelihood ratio of 9.78. Thus both the IDF and NCEP-ATPIII criteria may be equally useful in identifying MetS.Keywords
This publication has 24 references indexed in Scilit:
- Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart reviewSchizophrenia Research, 2008
- Metabolic Syndrome: A Multiplex Cardiovascular Risk FactorThe Journal of Clinical Endocrinology & Metabolism, 2007
- Does antipsychotic polypharmacy increase the risk for metabolic syndrome?Schizophrenia Research, 2007
- Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medicationSchizophrenia Research, 2006
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- The metabolic syndrome—a new worldwide definitionThe Lancet, 2005
- Medical Morbidity and Mortality in SchizophreniaThe Journal of Clinical Psychiatry, 2005
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Causes of the excess mortality of schizophreniaThe British Journal of Psychiatry, 2000
- Excess mortality of schizophreniaThe British Journal of Psychiatry, 1997